Enzyme-Linked Immunosorbent Assay helps clinical laboratories and healthcare settings to detect analytes and quantify substances such as peptides, proteins, antibodies and hormone in samples such as serum and plasma. According to the report published by market.us, the global Enzyme-Linked Immunosorbent Assay (ELISA) market that was valued at US$ 1,594.9 Mn in 2018 is expected to grow significantly at a CAGR of 5.5% from 2019 to 2028.
Key highlights of this report include:
This global market is classified on the basis of type, application and geography.
- Based on type, the market is segmented into ELISA Sets and ELISA Kits .
- By application, the market includes ELISA in HIV, ELISA in West Nile Virus, Detecting Antigens or Antibodies, and Biodefense
- Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa
Key players in this market include R&D Systems, Thermo Fisher Scientific , Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMérieux, EMD Millipore, BioLegend, LOEWE Biochemica and Shenzhen YHLO Biotech.
ELISA kits can be used to test for antibodies as well as antigens. These kits allow specific, quantitative and consistent measurements of soluble antigens found in human serum, plasma, and body fluids. Different categories of ELISA products include - Hormone Assays in Saliva, Hormone Assays, Infectious Disease Kits, Recombinant Proteins and Phospho-Specific Antibodies. Professional lab equipment suppliers also offer ELISA kits from manufacturers such as Stanbio and DRG International Inc, which include DRG Syphilis (Treponema pallidum) IgG ELISA, 96 wells, West Nile IgG ELISA, 96 wells , Stanbio True® 20 hCG Test Set (Urine), 50 Tests and more.